Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Nidhi Agarwal

Pfizer (PFE) vs. Johnson & Johnson (JNJ) - Analyzing Pharma Stocks for Upside Potential

In this article, I evaluated two pharma stocks, Pfizer Inc. (PFE) and Johnson & Johnson (JNJ), to asses which have higher growth potential. After thoroughly evaluating these stocks, I think JNJ might be the superior choice for the reasons discussed in this article.

The pharmaceutical market has experienced significant growth in recent years, driven by factors such as an aging global population, increasing prevalence of chronic diseases, advancements in medical technology, and rising healthcare awareness and expenditure. Global pharmaceutical market revenue is expected to grow at a 6.4% CAGR until 2032.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.